Single and Multiple Dose Escalation of PHIN-214 in Child-Pugh A and B Liver Cirrhotics
Conditions
Cirrhosis, Liver · Liver Fibrosis · Ascites Hepatic
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Arizona Liver Health, Chandler, Arizona, United States
Southern California Research Center, Coronado, California, United States
Tandem Clinical Research, Marrero, Louisiana, United States
Mayo Clinic, Rochester, Minnesota, United States
Cleveland Clinic, Cleveland, Ohio, United States
University of Pennsylvania, Philadelphia, Pennsylvania, United States
Contact: Study coordinator (Margaret Bussineau) · Margaret.Bussineau@Pennmedicine.upenn.edu · 215-615-3755Methodist Health System, Dallas Medical Center, Dallas, Texas, United States
VA North Texas Healthcare System, Dallas, Texas, United States
Contact: Principal Investigator (Jacqueline O'Leary, MD)Texas Liver Institute, San Antonio, Texas, United States
Study leads
Cynthia C Jones
Study Chair
PharmaIN